As expected, in condition allowing viral integration (conditions of infection by HIV-1 env−gfp+ WT virus in the absence of RAL), treatments stimulating the NF-κB pathway (i.e. TNF-α, PRO and PHA) promoted HIV-1 expression (Fig. 3). The gene discussed is NFKB1; the disease is infection.